title: How important is HER2/neu amplification and expression when selecting patients for HER2/neu-targeted therapies?
authors.affiliation: Immunotherapy and Blood and Stem Cell Transplantation Programs, Adele R. Decof Cancer Center, Roger Williams Medical Center, Providence, RI, USA.
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Davol
authors.forename: Lawrence G
authors.initials: LG
authors.lastname: Lum
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D005260:Female; D005784:Gene Amplification; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D007167:Immunotherapy; D017404:In Situ Hybridization, Fluorescence; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases